Still Pipette-Filling Cryovials? There’s a Better Way
In cell and gene therapy, where fill precision and cell viability can determine the success of an entire treatment, it's surprising how many...
Dr. Dave Seaward : 28 February 2022
As we continue to explore the world of cell and gene therapy, we now take a look at managing costs and scale up risks for medical devices.
Author Dave Seward, discusses how the principles of Quality by Design (QbD) and Design for Manufacture (DfM) can be applicable to ATMPs. Read this blog now!
In cell and gene therapy, where fill precision and cell viability can determine the success of an entire treatment, it's surprising how many...
Each year on 23 June, International Women in Engineering Day (INWED), led by the Women’s Engineering Society, shines a spotlight on the remarkable...
In the evolving field of cell and gene therapy (CGT), adherence to current Good Manufacturing Practice (cGMP) is crucial. This white paper provides...